Billionaire Profile
Roger Samuelsson
Global Rank
#1045

Image: Steptyro | CC BY-SA 4.0 | via Wikimedia Commons

Roger Samuelsson

CEO, Drug delivery devices
SWEDEN
Real-Time Net Worth
$4.141B
Estimated based on Drug delivery devices stock value as of April 20, 2026
0% (24h)
Age
62
Source
Drug delivery devices
Industry
Healthcare
Citizenship
SWEDEN

Biography

Roger Samuelsson is a Swedish entrepreneur and the owner of 68% of SHL Medical, the world's largest maker of autoinjectors. His wealth is primarily derived from his stake in SHL Medical, a company he co-founded in 1989. Samuelsson's career began with importing goods from Taiwan, later transitioning to medical device manufacturing. His achievements include pioneering autoinjectors, which have become essential for drug delivery. As of March 2026, his net worth is estimated at $4.1 billion, marking him as a self-made billionaire. He is also known for owning the megayacht Octopus and has been involved in car racing.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Entrepreneurial Beginnings

Roger Ivar Samuelsson, born on December 10, 1963, in Svalöv, Sweden, began his entrepreneurial journey at a young age. As a sports enthusiast, he observed the production of sporting goods in Asia, which sparked his interest in importing. He started by importing boxing gloves and other items from Taiwan, laying the foundation for his future business ventures. After studying engineering, Samuelsson moved to Taiwan to further his business interests.

Rise to Success

In 1989, Samuelsson co-founded Scandinavian Health Systems (SHL), initially operating from his apartment. The company transitioned from an import agency to a manufacturer, focusing on medical devices, particularly injectors and systems for individual drug distribution. SHL Medical grew significantly under Samuelsson's leadership, employing around 3,000 people by 2016. The company has factories in Taiwan and China, with development divisions in Taiwan, Sweden, and the USA. The company's success is linked to the rising demand for autoinjectors, used for administering various medications, including those for weight loss and other chronic conditions. SHL Medical's clients include major pharmaceutical companies like Novo Nordisk, Amgen, and Pfizer.

Key Business Strategies

Samuelsson's approach to business is characterized by careful observation, attentive listening, thorough thinking, and decisive execution. SHL Medical's success is built on a foundation of innovation and strategic partnerships within the healthcare industry. The company has consistently upgraded its manufacturing and commercial capabilities. His company focuses on the development and manufacture of advanced drug delivery devices, such as autoinjectors, pen injectors, and innovative specialty delivery systems.

Philanthropy

While specific details of Roger Samuelsson's philanthropy are not readily available in the search results, his involvement and ownership of the Race4Health team, which combines motorsports with charitable initiatives, suggests an interest in using his resources for positive global change.

Career Milestones

1989

Co-founded SHL Medical

Established SHL Medical, which became a leading manufacturer of autoinjectors.

2021

Purchased the Octopus Yacht

Acquired the megayacht Octopus, previously owned by Paul Allen.

2024

Billionaire Status

Achieved billionaire status due to the success of SHL Medical.

Business Philosophy & Leadership

Notable Quotes

"Roger's mantra is 'look around very carefully, listen very attentively, think a long time and then execute like hell.'"

Leadership Principles

Strategic Execution

The ability to execute business strategies effectively is key to success.

Focus on Innovation

SHL Medical's success comes from the constant improvement of their products.